Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-05 09:44 am Purchase | 2025-12-31 | 13G | VERASTEM INC VSTM | Polar Capital Holdings Plc | 3,398,899 5.090% | 3,398,899 (New Position) | Filing History |
| 2025-09-04 11:06 am Purchase | 2025-06-30 | 13G | HAGERTY INC CLASS A HGTY | Polar Capital Holdings Plc | 5,306,865 5.850% | 5,306,865 (New Position) | Filing History |
| 2025-08-14 08:05 am Sale | 2025-06-30 | 13G | HAGERTY INC CLASS A HGTY | Polar Capital Holdings Plc | 0 0.000% | -5,002,477 (Position Closed) | Filing History |
| 2025-08-14 08:04 am Sale | 2025-06-30 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Polar Capital Holdings Plc | 5,006,472 4.200% | -1,700,003 (-25.35%) | Filing History |
| 2025-08-14 08:01 am Purchase | 2025-06-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Polar Capital Holdings Plc | 2,536,881 5.170% | 147,213 (+6.16%) | Filing History |
| 2025-05-15 10:21 am Purchase | 2025-03-31 | 13G | NEUROPACE INC NPCE | Polar Capital Holdings Plc | 2,972,003 9.130% | 2,972,003 (New Position) | Filing History |
| 2025-05-15 10:13 am Purchase | 2025-03-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Polar Capital Holdings Plc | 6,706,475 5.650% | 408,787 (+6.49%) | Filing History |
| 2025-02-14 09:18 am Sale | 2024-12-31 | 13G | VTEX VTEX | Polar Capital Holdings Plc | 5,232,020 2.840% | -5,306,653 (-50.35%) | Filing History |
| 2025-02-14 09:17 am Sale | 2024-12-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Polar Capital Holdings Plc | 2,389,668 4.890% | -298,129 (-11.09%) | Filing History |
| 2024-11-13 6:01 pm Purchase | 2024-09-30 | 13G | BRUKER CORPORATION COM BRKR | Polar Capital Holdings Plc | 317,928 0.210% | 317,928 (New Position) | Filing History |
| 2024-11-13 6:00 pm Sale | 2024-09-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Polar Capital Holdings Plc | 2,711,163 4.090% | -424,708 (-13.54%) | Filing History |
| 2024-11-13 5:58 pm Sale | 2024-09-30 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 4,803,899 4.990% | -1,947,883 (-28.85%) | Filing History |
| 2024-11-13 5:57 pm Purchase | 2024-09-30 | 13G | VTEX VTEX | Polar Capital Holdings Plc | 10,538,673 5.700% | 10,538,673 (New Position) | Filing History |
| 2024-11-13 5:56 pm Purchase | 2024-09-30 | 13G | HAGERTY INC CLASS A HGTY | Polar Capital Holdings Plc | 5,002,477 5.570% | 5,002,477 (New Position) | Filing History |
| 2024-11-13 5:55 pm Purchase | 2024-09-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Polar Capital Holdings Plc | 2,687,797 5.690% | 2,687,797 (New Position) | Filing History |
| 2024-02-13 09:41 am Purchase | 2023-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Polar Capital Holdings Plc | 3,135,871 5.730% | 3,135,871 (New Position) | Filing History |
| 2024-02-13 09:40 am Purchase | 2023-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 6,751,782 7.510% | 4,251,782 (+170.07%) | Filing History |
| 2024-02-13 09:39 am Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Polar Capital Holdings Plc | 500,000 1.050% | 342,552 (+217.57%) | Filing History |
| 2024-02-13 09:39 am Sale | 2023-12-31 | 13G | REVANCE THERAPEUTICS INC RVNC | Polar Capital Holdings Plc | 3,169,239 3.600% | -1,679,394 (-34.64%) | Filing History |
| 2024-02-13 09:27 am Purchase | 2023-12-31 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | Polar Capital Holdings Plc | 3,975,000 8.260% | 196,269 (+5.19%) | Filing History |